KEYNOTE-024: Phase III trial of pembrolizumab (MK-3475) vs platinum-based chemotherapy as first-line therapy for patients with metastatic non-small cell lung cancer (NSCLC) that expresses programmed cell death ligand 1 (PD-L1).-Reference-Cited by-同舟云学术

KEYNOTE-024: Phase III trial of pembrolizumab (MK-3475) vs platinum-based chemotherapy as first-line therapy for patients with metastatic non-small cell lung cancer (NSCLC) that expresses programmed cell death ligand 1 (PD-L1).

Published:2015-05-20 Issue:15_suppl Volume:33 Page:TPS8103-TPS8103
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Brahmer Julie R.¹,Kim Edward S.²,Zhang Jin³,Smith Margaret Marie³,Rangwala Reshma A.³,O'Brien Mary E.R.⁴

Affiliation:

1. The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD

2. Levine Cancer Institute, Carolinas Healthcare System, Charlotte, NC

3. Merck & Co., Inc., Kenilworth, NJ

4. Royal Marsden Hospital, London, United Kingdom

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/jco.2015.33.15_suppl.tps8103

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies and End Points in the Development of Novel Immunotherapy Trials for Patients With Unresectable, Locally Advanced Non–Small-Cell Lung Cancer;Journal of Clinical Oncology;2022-10-10

2. Impact of performance status on non-small-cell lung cancer patients with a PD-L1 tumour proportion score ≥50% treated with front-line pembrolizumab;Acta Oncologica;2020-06-17

3. Association Between Immune-related Adverse Events and Efficacy of Immune Checkpoint Inhibitors in Non–small-cell Lung Cancer;Clinical Lung Cancer;2019-05

4. The frequency of high PD-L1 expression is low in lung adenocarcinoma patients from Northeast Brazil;Surgical and Experimental Pathology;2019-02-18

5. Prognostic Significance of Phosphorylated Fyn in Patients with Lung Adenocarcinoma after Lung Resection;Annals of Thoracic and Cardiovascular Surgery;2019